ALPINE GROUP PARTNERS, LLC.

Lobbying for AMGEN

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $50,000.00 income · posted Apr 10, 2025

Lobbying activity 1

Medicare/Medicaid

Issues related to Part D rebates Proposals related to drug pricing, drug price transparency, PBMS Implementation of the Inflation Reduction Act

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.